ArticleClinical, cosmetic and investigational dermatology2023

Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study.

Filomena Russo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.